NEUROTIME
DEAD

Serial Number

79386938

Owner

neuroTime GmbH

Filing Date

Nov 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NEUROTIME Trademark

Serial Number: 79386938

NEUROTIME is a trademark filed by neuroTime GmbH on November 17, 2023. The trademark is classified under Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

neuroTime GmbH

c/o Anthropia gGmbH,

Entity Type: 98

Niels Schepers

Großglocknerstraße 2

Entity Type: 01

Trademark Details

Filing Date

November 17, 2023

Registration Date

Not Registered

Goods & Services

Downloadable software for digital end devices for monitoring, analyzing, controlling for children with autism; information technology and audio-visual, multimedia and photographic devices for children with autism; computer peripheral devices for data reproduction for children with autism

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 30, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 30, 2025 ABN2
REFUSAL PROCESSED BY IB
Jul 5, 2025 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 20, 2025 OPNX
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 17, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 10, 2025 RFCR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 3, 2025 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 28, 2025 NREP
CHANGE OF OWNER RECEIVED FROM IB
Nov 15, 2024 CHLD
NON-FINAL ACTION WRITTEN
Aug 2, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Aug 1, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 11, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 10, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 9, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 5, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 5, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 4, 2024 REPR